Ferlay, J. et al. Oesophageal Cancer Incidence and Mortality Worldwide in 2008. GLOBOCAN 2008[online], (2008).
Cancer Facts & Figures 2012. American Cancer Society[online], (2012).
Kamangar, F., Dores, G. M. & Anderson, W. F. Patterns of cancer incidence, mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol.24, 2137–2150 (2006). ArticlePubMed Google Scholar
Vaughan, T. L., Davis, S., Kristal, A. & Thomas, D. B. Obesity, alcohol and tobacco as risk factors for cancer of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev.4, 85–92 (1995). CASPubMed Google Scholar
Blot, W. J., Devesa, S. S., Kneller, R. W. & Fraumeni, J. F. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA265, 1287–1289 (1991). ArticleCASPubMed Google Scholar
Blot, W. J., Devesa, S. S. & Fraumeni, J. F. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA270, 1320 (1993). ArticleCASPubMed Google Scholar
Vial, M., Grande, L. & Pera, M. Epidemiology of adenocarcinoma of the esophagus, gastric cardia and upper gastric third. Recent Results Cancer Res.182, 1–17 (2010). PubMed Google Scholar
Crosby, T., Evans, M., Gillies, R. & Maynard, N. D. The management of a patient with an operable carcinoma of the oesophagus. Ann. R. Coll. Surg. Engl.91, 366–370 (2009). ArticlePubMedPubMed Central Google Scholar
Crew, K. D. & Neugut, A. I. Epidemiology of upper gastrointestinal malignancies. Semin. Oncol.31, 450–464 (2004). ArticlePubMed Google Scholar
Pohl, H., Sirovich, B. & Welch, H. G. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol. Biomarkers Prev.19, 1468–1470 (2010). ArticlePubMed Google Scholar
Curado, M. P. et al. (Eds) in Cancer Incidence in Five Continents Vol. IX. (IARC Scientific Publication No. 160, Lyon, 2007). Google Scholar
Zambon, P. et al. Smoking, type of alcoholic beverage and squamous-cell oesophageal cancer in northern Itlay. Int. J. Cancer86, 144–149 (2000). ArticleCASPubMed Google Scholar
Cook, M. B., Chow, W. H. & Devesa, S. S. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005. Br. J. Cancer101, 855–859 (2009). ArticleCASPubMedPubMed Central Google Scholar
Yang, C. S. Research on esophageal cancer in China: a review. Cancer Res.40 (8 Pt 1), 2633–2644 (1980). CASPubMed Google Scholar
Babaei, M. et al. Cancer occurrence in Semnan province, Iran: results of a population-based cancer registry. Asian Pac. J. Cancer Prev.6, 159–164 (2005). PubMed Google Scholar
Haghdoost, A. A. et al. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran. Arch. Iran. Med.11, 364–370 (2008). PubMed Google Scholar
Botterweck, A. A., Schouten, L. J., Volovics, A., Dorant, E. & van Den Brandt, P. A. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int. J. Epidemiol.29, 645–654 (2000). ArticleCASPubMed Google Scholar
Lindblad, M., Ye, W., Lindgren, A. & Lagergren, J. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann. Surg.243, 479–485 (2006). ArticlePubMedPubMed Central Google Scholar
Engel, L. S. et al. Population attributable risks of esophageal and gastric cancers. J. Natl Cancer Inst.95, 1404–1413 (2003). ArticlePubMed Google Scholar
Rubenstein, J. H. & Taylor, J. B. Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Aliment. Pharmacol. Ther.32, 1222–1227 (2010). ArticleCASPubMedPubMed Central Google Scholar
Erichsen, R. et al. Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with nonerosive reflux. Clin. Gastroenterol. Hepatol.10, 475–480 (2012). ArticlePubMed Google Scholar
Hvid-Jensen, F., Pedersen, L., Drewes, A. M., Sørensen, H. T. & Funch-Jensen, P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N. Engl. J. Med.365, 1375–1383 (2011). ArticleCASPubMed Google Scholar
Hampel, H., Abraham, N. S. & El-Serag, H. B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann. Intern. Med.143, 199–211 (2005). ArticlePubMed Google Scholar
Cook, M. B. et al. Cigarette smoking and adencarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J. Natl Cancer Inst.102, 1344–1353 (2010). ArticleCASPubMedPubMed Central Google Scholar
Freedman, J., Ye, W., Näslund, E. & Lagergren, J. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology121, 548–553 (2001). ArticleCASPubMed Google Scholar
Rokkas, T., Pistiolas, D., Sechopoulos, P., Robotis, I. & Margantinis, G. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin. Gastroenterol. Hepatol.5, 1413–1417 (2007). ArticlePubMed Google Scholar
Vicari, J. J. et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology115, 50–57 (1998). ArticleCASPubMed Google Scholar
Brown, L. M. et al. Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J. Natl Cancer Inst.86, 1340–1345 (1994). ArticleCASPubMed Google Scholar
Zendehdel, K., Nyrén, O., Edberg, A. & Ye, W. Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am. J. Gastroenterol.106, 57–61 (2011). ArticlePubMed Google Scholar
Stiff, G., Alwafi, A., Rees, B. I. & Lari, J. Corrosive injuries of esophagus and stomach: experience in management in regional pediatric center. Ann. R. Coll. Surg. Engl.78, 119–123 (1996). CASPubMedPubMed Central Google Scholar
Appelqvist, P. & Salmo, M. Lye corrosion carcinoma of the esophagus: a review of 63 cases. Cancer45, 2655–2658 (1980). ArticleCASPubMed Google Scholar
Boone, J., Livestro, D. P., Elias, S. G., Borel Rinkes, I. H. & van Hillegersberg, R. International survey on esophageal cancer: part II staging and neoadjuvant therapy. Dis. Esophagus22, 203–210 (2009). ArticleCASPubMed Google Scholar
Levine, M. S. & Rubesin, S. E. Diseases of the esophagus: diagnosis with esophagography. Radiology237, 414–427 (2005). ArticlePubMed Google Scholar
Goldstein, H. M. & Dodd, G. D. Double-contrast examination of the esophagus. Gastrointest. Radiol.1, 3–6 (1976). ArticleCASPubMed Google Scholar
Levine, M. S., Rubesin, S. E. & Laufer, I. Barium esophagography: a study for all seasons. Clin. Gastroenterol. Hepatol.6, 11–25 (2008). ArticlePubMed Google Scholar
Levine, S. L. et al. Carcinoma of the esophagus and esophagogastric junction: sensitivity of radiographic diagnosis. AJR Am. J. Roentgenol.168, 1423–1426 (1997). ArticleCASPubMed Google Scholar
Agrawal, A. & Wenig, B. L. Screening for simultaneous esophageal primary tumors. Endoscopy vs esophagography. Arch. Otolaryngol. Head Neck Surg.124, 930–932 (1998). ArticleCASPubMed Google Scholar
Fornari, F. & Wagner, R. Update on endoscopic diagnosis, management and surveillance strategies of esophageal disease. World J. Gastrointest. Endosc.4, 117–122 (2012). ArticlePubMedPubMed Central Google Scholar
Connor, M. J. & Sharma, P. Chromoendoscopy and magnification endoscopy in Barrett esophagus. Gastrointest. Endosc. Clin. N. Am.13, 269–277 (2003). ArticlePubMed Google Scholar
Ormeci, N. et al. The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma. Surg. Endosc.22, 693–700 (2008). ArticleCASPubMed Google Scholar
Connor, M. J. & Sharma, P. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia. Thorac. Surg. Clin.14, 87–94 (2004). ArticlePubMed Google Scholar
Ide, E., Maluf-Filho, F., Chaves, D. M., Matuguma, S. E. & Sakai, P. Narrow-band imaging without magnification for detecting early esophageal squamous cell carcinoma. World J. Gastroenterol.17, 4408–4413 (2011). ArticlePubMedPubMed Central Google Scholar
Barros Lopes, A. & Borges Fagundes, R. Esophageal squamous cell carcinoma—precursor lesions and early diagnosis. World J. Gastrointest. Endosc.4, 9–16 (2012). Article Google Scholar
Yoshida, T. et al. Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest. Endosc.59, 288–295 (2004). ArticlePubMed Google Scholar
Suzuki, H., Saito, Y., Ikehara, H. & Oda, I. Evaluation of visualization of squamous cell carcinoma of esophagus and pharynx using an Autofluorescence imaging videoendoscope system. J. Gastroenterol. Hepatol.24, 1834–1839 (2009). ArticlePubMed Google Scholar
Yoshida, Y. et al. Assessment of novel endoscopic techniques for visualizing superficial esophageal squamous cell carcinoma: autofluorescence and narrow band imaging. Dis. Esophagus22, 439–446 (2009). ArticleCASPubMed Google Scholar
Heuberger, D., Manner, H., Ell, C. & Pech, O. How is early Barrett's cancer currently diagnosed and treated in Western Europe? Results of a survey at 52 university hospitals in eight Western European countries. Z. Gastroenterol.50, 670–676 (2012). ArticleCASPubMed Google Scholar
Dittler, H. J., Pesarini, A. C. & Siewert, J. R. Endoscopic classification of esophageal cancer: correlation with the T stage. Gastrointest. Endosc.38, 662–668 (1992). ArticleCASPubMed Google Scholar
Dittler, H. J. & Siewert, J. R. Role of endoscopic ultrasonography in esophageal carcinoma. Endoscopy25, 156–161 (1993). ArticleCASPubMed Google Scholar
Van Vliet, E. P., Heijenbrok-Kal, M. H., Hunink, M. G. M., Kuipers, E. J. & Siersema, P. D. Staging investigations for oesophageal cancer: a meta-analysis. Br. J. Cancer98, 547–557 (2008). ArticleCASPubMedPubMed Central Google Scholar
Cerfolio, R. J., Bryant, A. S., Ohja, B., Bartolucci, A. A. & Eloubeidi, M. A. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy. J. Thorac. Cardiovasc. Surg.129, 1232–1241 (2005). ArticlePubMed Google Scholar
McClave, S. A., Jones, W. F. & Evans, W. B. Do physician attitudes and practices limit use of EUS in the staging and the treatment of esophageal carcinoma? Gastrointest. Endosc.61, 840–848 (2005). ArticlePubMed Google Scholar
Kato, H. et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer103, 148–156 (2005). ArticlePubMed Google Scholar
Kato, H. et al. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res.25, 4439–4444 (2005). PubMed Google Scholar
Van Westreenen, H. L. et al. Limited additional value of positron emission tomography in staging esophageal cancer. Br. J. Surg.94, 1515–1520 (2007). ArticleCASPubMed Google Scholar
Gillies, R. S., Middleton, M. R., Maynard, N. D., Bradley, K. M. & Gleeson, F. V. Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer. Eur. Radiol.21, 274–280 (2011). ArticleCASPubMed Google Scholar
Noble, F., Bailey, D., SWCIS Upper Gastrointestinal Tumour Panel, Tung, K. & Byrne, J. P. Impact of integrated PET/CT in the staging of oesophageal cancer: a UK population-based cohort study. Clin. Radiol.64, 699–705 (2009). ArticleCASPubMed Google Scholar
Gillies, R. S. et al. Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma. Br. J. Surg.99, 239–245 (2012). ArticleCASPubMed Google Scholar
Ott, K., Weber, W. & Siewert, J. R. The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis. Esophagus19, 433–442 (2006). ArticleCASPubMed Google Scholar
Weber, W. A. et al. Prediction of response to preoperative chemotherapy in adenocarcinoma of the esophagogastric junction by metabolic imaging. J. Clin. Oncol.19, 3058–3065 (2001). ArticleCASPubMed Google Scholar
Ott, K. et al. Metabolic imaging predicts response, survival and recurrence in adenocarcinoma of the esophagogastric junction. J. Clin. Oncol.24, 4692–4698 (2006). ArticlePubMed Google Scholar
Theissen, J. et al. Early response evaluation and prediction in neoadjuvant-treated patients with esophageal cancer. World J. Gastrointest. Surg.1, 30–37 (2009). Google Scholar
Omloo, J. M. T. et al. FDG-PET parameters as prognostic factor in esophageal cancer patients: a review. Ann. Surg. Oncol.18, 3338–3352 (2011). ArticleCASPubMedPubMed Central Google Scholar
Wieder, H. A. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response of treatment. J. Clin. Oncol.22, 900–908 (2004). ArticleCASPubMed Google Scholar
Westerterp, M. et al. Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET. Int. J. Hyperthermia22, 149–160 (2006). ArticleCASPubMed Google Scholar
Vallböhmer, D. et al. [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann. Surg.250, 888–894 (2009). ArticlePubMed Google Scholar
Levine, E. A. et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann. Surg.243, 472–478 (2006). ArticlePubMedPubMed Central Google Scholar
Gillham, C. M. et al. 18FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response. Br. J. Cancer95, 1174–1179 (2006). ArticleCASPubMedPubMed Central Google Scholar
Van Heijl, M. et al. NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial). BMC Med. Phys.8, 3 (2008). ArticlePubMedPubMed Central Google Scholar
Van Heijl, M. et al. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. Ann. Surg.253, 56–63 (2011). ArticlePubMed Google Scholar
Gluckman, J. L. & Crissman, J. D. Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract. Laryngoscope93, 71–74 (1983). CASPubMed Google Scholar
Vrabec, D. P. Multiple primary malignancies of the upper aerodigestive system. Ann. Otol. Rhinol. Laryngol.88, 846–854 (1979). ArticleCASPubMed Google Scholar
Riedel, M. et al. Preoperative bronchoscopic assessment of airway invasion by esophageal cancer: a prospective study. Chest113, 687–695 (1998). ArticleCASPubMed Google Scholar
Cheng, S. L. et al. The role of bronchoscopic assessment in esophageal cancer—clinical and survival analysis in 153 patients. J. Formos. Med. Assoc.104, 168–173 (2005). PubMed Google Scholar
Garrido, T. et al. Endobronchial ultrasound application for diagnosis of tracheobronchial tree invasion by esophageal cancer. Clinics64, 499–504 (2009). ArticlePubMedPubMed Central Google Scholar
Nishimura, Y. et al. Bronchoscopic ultrasonography in the diagnosis of tracheobronchial invasion of esophageal cancer. J. Ultrasound Med.21, 49–58 (2002). ArticlePubMed Google Scholar
Osugi, H. et al. Bronchoscopic ultrasonography for staging supracarinal esophageal squamous cell carcinoma: impact on outcome. World J. Surg.27, 590–594 (2003). ArticlePubMed Google Scholar
Mealy, K. et al. Tumour marker detection in oesophageal carcinoma. Eur. J. Oncol.22, 505–507 (1996). ArticleCAS Google Scholar
Brockmann, J. G., Nottberg, H. S., Glodny, B., Heinecke, A. & Senninger, N. J. CYFRA 21–21 serum analysis in patients with esophageal cancer. Clin. Cancer Res.6, 4249–4252 (2000). CASPubMed Google Scholar
Quillien, V., Raoul, J. L., Laurent, J. F., Meunier, B. & Le Prise, E. Comparison of Cyfra 21–21, TPA and SCC tumor markers in esophageal squamous cell carcinoma. Oncol. Rep.5, 1561–1565 (1998). CASPubMed Google Scholar
Yan, H. I. et al. Cytokeratin 19 fragment antigen 21–21 as an independent predictor for definitive chemoradiotherapy sensitivity in esophageal squamous cell carcinoma. Chin. Med. J.125, 1410–1415 (2012). CASPubMed Google Scholar
Yi, Y. et al. CYFRA 21–21 and CEA are useful markers for predicting the sensitivity to chemoradiotherapy of esophageal squamous cell carcinoma. Biomarkers14, 480–485 (2009). ArticleCASPubMed Google Scholar
Blanchard, P. et al. Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy. BMC Cancer12, 119 (2012). ArticlePubMedPubMed Central Google Scholar
Boone, J., Livestro, D. P., Elias, S. G., Borel Rinkes, I. H. & van Hillegersberg, R. International survey on esophageal cancer: part I surgical techniques. Dis. Esophagus22, 195–202 (2009). ArticlePubMed Google Scholar
Pech, O. et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut57, 1200–1206 (2008). ArticleCASPubMed Google Scholar
Pech, O. et al. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Ann. Surg.254, 67–72 (2011). ArticlePubMed Google Scholar
Honda, K. & Akiho, H. Endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. World J. Gastrointest. Pathophysiol.3, 44–50 (2012). ArticlePubMedPubMed Central Google Scholar
Yoshii, T., Ohkawa, S., Tamai, S. & Kameda, Y. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading mucularis mucosa and submucosal layer. Dis. Esophagushttp://dx.doi.org/10.1111/j.1442-20502012.01370.x.
Yamashina, T. et al. Safety and curative ability of endoscopic submucosal dissection for superficial esophageal cancers at least 50 mm in diameter. Dig. Endosc.24, 220–225 (2012). ArticlePubMed Google Scholar
Ono, S. et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest. Endosc.70, 860–866 (2009). ArticlePubMed Google Scholar
Repici, A. et al. Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series. Gastrointest. Endosc.71, 715–721 (2010). ArticlePubMed Google Scholar
Kim, H. P. et al. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest. Endosc.76, 733–739 (2012). ArticlePubMedPubMed Central Google Scholar
Stein, H. J., Feith, M., Mueller, J., Werner, M. & Siewert, J. R. Limited resection for early adenocarcinoma in Barrett's esophagus. Ann. Surg.232, 733–742 (2000). ArticleCASPubMedPubMed Central Google Scholar
Stein, H. J. & Feith, M. Surgical strategies for early esophageal adenocarcinoma. Best Pract. Res. Clin. Gastroenterol.19, 927–940 (2005). ArticleCASPubMed Google Scholar
Stein, H. J., Hutter, J., Feith, M. & von Rahden, B. H. Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus. Semin. Thorac. Cardiovasc. Surg.19, 72–78 (2007). ArticlePubMed Google Scholar
Merendino, K. A. & Dillard, D. H. The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices. Ann. Surg.142, 486–506 (1955). ArticleCASPubMedPubMed Central Google Scholar
Tachibana, M. et al. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma. Am. J. Surg.189, 98–109 (2005). ArticlePubMed Google Scholar
Walther, B., Johansson, J., Johnsson F., von Holstein, C. S. & Zilling, T. Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction. Ann. Surg.238, 803–814 (2003). ArticlePubMedPubMed Central Google Scholar
Cense, H. A. et al. Quality of life after colon interposition be necessity for esophageal cancer replacement. J. Surg. Oncol.88, 32–38 (2004). ArticlePubMed Google Scholar
Abunasra, H. et al. Predictors of operative death after oesophagectomy for carcinoma. Br. J. Surg.92, 1029–1033 (2005). ArticleCASPubMed Google Scholar
Mariette, C., Taillier, G., Van Seuningen, I. & Triboulet, J. P. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann. Thorac. Surg.78, 1177–1183 (2004). ArticlePubMed Google Scholar
Lerut, T. et al. Anastomotic complications after esophagectomy. Dig. Surg.19, 92–98 (2002). CAS Google Scholar
Alanezi, K. & Urschel, J. D. Mortality secondary to esophageal anastomotic leak. Ann. Thorac. Cardiovasc. Surg.10, 71–75 (2004). PubMed Google Scholar
Lagergren, P. et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer110, 686–693 (2007). ArticlePubMed Google Scholar
Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet359, 1727–1733 (2002).
Omloo, J. M. T. et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus. Five-year survival of a randomized clinical trial. Ann. Surg.246, 992–1001 (2007). ArticlePubMed Google Scholar
Grotenhuis, B. A. et al. Surgical management of submucosal esophageal cancer. Extended or regional lymphadenectomy? Ann. Surg.252, 823–830 (2010). ArticlePubMed Google Scholar
Orringer, M. B. & Sloan, H. Esophagectomy without thoracotomy. J. Thorac. Cardiovasc. Surg.76, 643–654 (1978). CASPubMed Google Scholar
Orringer, M. B. et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann. Surg.246, 363–372 (2007). ArticlePubMedPubMed Central Google Scholar
Chang, A. C., Ji, H., Birkmeyer, N. J., Orringer, M. B. & Birkmeyer, J. D. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann. Thorac. Surg.85, 424–429 (2008). ArticlePubMed Google Scholar
Hulscher, J. B. F. et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N. Engl. J. Med.347, 1662–1669 (2002). ArticlePubMed Google Scholar
Van Hagen, P. et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N. Engl. J. Med.366, 2074–2084 (2012). ArticleCASPubMed Google Scholar
Pennathur, A., Awais, O. & Luketich, J. D. Technique of minimally invasive Ivor Lewis esophagectomy. Ann. Thorac. Surg.89, S2159–S2162 (2010). ArticlePubMed Google Scholar
Nguyen, N. T. et al. Minimally invasive esophagectomy: lessons learned from 104 operations. Ann. Surg.248, 1081–1091 (2008). ArticlePubMed Google Scholar
Biere, S. S., Cuesta, M. A. & van der Peet, D. L. Minimally invasive versus open esophagectomy for cancer: a systematic review and meta-analysis. Minerva Chir.64, 121–133 (2009). CASPubMed Google Scholar
Verhage, R. J., Hazebroek, E. J., Boone, J. & Van Hillegersberg, R. Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir.64, 135–146 (2009). CASPubMed Google Scholar
Biere, S. S. et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomized controlled trial. Lancet379, 1887–1892 (2012). ArticlePubMed Google Scholar
Mamidanna, R., Bottle, A., Aylin, P., Faiz, O. & Hanna, G. B. Short-term outcomes following open versus minimally invasive esophagectomy for cancer in England: a population-based national study. Ann. Surg.255, 197–203 (2012). ArticlePubMed Google Scholar
Luketich, J. D. et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann. Surg.256, 95–103 (2012). ArticlePubMed Google Scholar
Avital, S., Zundel, N., Szomstein, S. & Rosenthal, R. Laparoscopic transhiatal esophagectomy for esophageal cancer. Am. J. Surg.190, 69–74 (2005). ArticlePubMed Google Scholar
Sanders, G. et al Minimally invasive transhiatal esophagectomy: lessons learned. Surg. Endosc.21, 1190–1193 (2007). ArticlePubMed Google Scholar
Scheepers, J. J. G. et al. Laparoscopic transhiatal resection for malignancies of the distal esophagus: outcome of the first 50 resected patients. Surgery143, 278–285 (2008). ArticlePubMed Google Scholar
Dapri, G., Himpens, J. & Cadiere, G. B. Minimally invasive esophagectomy for cancer: laparoscopic transhiatal procedure or thoracoscopy in prone position followed by laparoscopy? Surg. Endosc.22, 1060–1069 (2008). ArticleCASPubMed Google Scholar
Galvani, C. A. et al. Robotically assisted laparoscopic transhiatal esophagectomy. Surg. Endosc.22, 188–195 (2008). ArticleCASPubMed Google Scholar
Boone, J., Borel Rinkes, I. H. M. & van Hillegersberg, R. Transhiatal robot-assisted esophagectomy. Surg. Endosc.22, 1139–1140 (2008). ArticleCASPubMedPubMed Central Google Scholar
Kim, D. J. et al. Thoracoscopic esophagectomy for esophageal cancer: feasibility and safety of robot assistance in the prone position. J. Thorac. Cardiovasc. Surg.139, 53–59 (2010). ArticlePubMed Google Scholar
Van Hillegersberg, R. et al. First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg. Endosc.20, 1435–1439 (2006). ArticleCASPubMed Google Scholar
Walsh, T. N. et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N. Engl. J. Med.335, 462–467 (1996). ArticleCASPubMed Google Scholar
Allum, W. H., Stenning, S. P., Bancewicz, J., Clark, P. I. & Langley, R. E. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J. Clin. Oncol.27, 5062–5067 (2009). ArticlePubMed Google Scholar
Cunningham, D. et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med.355, 11–20 (2006). ArticleCASPubMed Google Scholar
Boonstra, J. J. et al. Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: long-term results of a randomized controlled trial. BMC Cancer11, 181–191 (2011). ArticleCASPubMedPubMed Central Google Scholar
Forastiere, A., Orringer, M. B., Perez-Tamayo, C., Urba, S. G. & Zahurak, M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus. J. Clin. Oncol.11, 1118–1123 (1993). ArticleCASPubMed Google Scholar
Bates, B. A., Detterbeck, F. C., Bernard, S. A., Qaqish, B. F. & Tepper, J. E. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J. Clin. Oncol.14, 156–163 (1996). ArticleCASPubMed Google Scholar
Donington, J. S. et al. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur. J. Cardiothorac. Surg.24, 631–636 (2003). ArticlePubMed Google Scholar
Kleinberg, L. & Forastiere, A. A. Chemoradiation in the management of esophageal cancer. J. Clin. Oncol.25, 4110–4117 (2007). ArticleCASPubMed Google Scholar
Kelsen, D. P. et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N. Engl. J. Med.339, 1979–1984 (1998). ArticleCASPubMed Google Scholar
Kelsen, D. P. et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J. Clin. Oncol.25, 3719–3725 (2007). ArticlePubMed Google Scholar
Stahl, M. et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J. Clin. Oncol.23, 2310–2317 (2005). ArticlePubMed Google Scholar
Morgan, M. A. et al. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal cancer. Br. J. Surg.96, 1300–1307 (2009). ArticleCASPubMed Google Scholar
Luu, T. D. et al. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Ann. Thorac. Surg.85, 1217–1223 (2008). ArticlePubMed Google Scholar
Wijnhoven, B. P., van Lanschot, J. J., Tilanus, H. W., Steyerberg, E. W. & van der Gaast, A. Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses. World J. Surg.33, 2606–2614 (2009). ArticlePubMedPubMed Central Google Scholar
Urschel, J. D. & Vasan, H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am. J. Surg.185, 538–543 (2003). ArticlePubMed Google Scholar
Sjoquist, K. M. et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol.12, 681–692 (2011). ArticlePubMed Google Scholar
D'Amico, T. A. Outcomes after surgery for esophageal cancer. Gastrointest. Cancer Res.1, 188–196 (2007). PubMedPubMed Central Google Scholar
Herskovic, A. et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N. Engl. J. Med.326, 1593–1598 (1992). ArticleCASPubMed Google Scholar
Cooper, J. S. et al. Chemoradiotherapy of locally advanced esophageal cancer: long term follow up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology Group. JAMA281, 1623–1627 (1999). ArticleCASPubMed Google Scholar
Minsky, B. D. et al. Final report of Intergroup trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int. J. Radiat. Oncol. Biol. Phys.43, 517–523 (1999). ArticleCASPubMed Google Scholar
Minsky, B. D. et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J. Clin. Oncol.20, 1167–1174 (2002). ArticleCASPubMed Google Scholar
Bedenne, L. et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J. Clin. Oncol.25, 1160–1168 (2007). ArticleCASPubMed Google Scholar
Gwynne, S. et al. Definitive chemoradiation for oesophageal cancer—a standard of care in patients with non-metastatic oesophageal cancer. Clin. Oncol. (R. Coll. Radiol.)23, 182–188 (2011). ArticleCAS Google Scholar
Tachimori, Y. Role of salvage esophagectomy after definitive chemoradiotherapy. Gen. Thorac. Cardiovasc. Surg.57, 71–78 (2009). ArticlePubMed Google Scholar
Gardner-Thorpe, J., Hardwick, R. H. & Dwerryhouse, S. J. Salvage oesophagectomy after local failure of definitive chemoradiotherapy. Br. J. Surg.94, 1059–1066 (2007). ArticleCASPubMed Google Scholar
Borghesi, S., Hawkins, M. A. & Tait, D. Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer. Clin. Oncol. (R. Coll. Radiol.)20, 221–226 (2008). ArticleCAS Google Scholar
Tachimori, Y. et al. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J. Thorac. Cardiovasc. Surg.137, 49–54 (2009). ArticlePubMed Google Scholar
Chao, Y. K. et al. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus. Eur. J. Surg. Oncol.35, 289–294 (2009). ArticleCASPubMed Google Scholar
Daly, J. M., Karnell, L. H. & Menck, H. R. National Cancer Data Base report on esophageal cancer. Cancer78, 1820–1828 (1996). ArticleCASPubMed Google Scholar
Mannell, A., Becker, P. J. & Nissenbaum, M. Bypass surgery for unresectable oesophageal cancer: early and late results in 124 cases. Br. J. Surg.75, 283–286 (1988). ArticleCASPubMed Google Scholar
Hirai, T. et al. Bypass operation for advanced esophageal cancer--an analysis of 93 cases. Jpn J. Surg.19, 182–188 (1989). ArticleCASPubMed Google Scholar
Meunier, B. et al. Gastric bypass for malignant esophagotracheal fistula: a series of 21 cases. Eur. J. Cardiothorac. Surg.13, 184–188 (1998). ArticleCASPubMed Google Scholar
Caspers, R. J., Welvaart, K., Verkes, R. J., Hermans, J. & Leer, J. W. The effect of radiotherapy on dysphagia and survival in patients with esophageal cancer. Radiother. Oncol.12, 15–23 (1988). ArticleCASPubMed Google Scholar
O'Rourke, I. C., Tiver, K., Bull., C., Gebski, V. & Langlands, A. O. Swallowing performance after radiation therapy for carcinoma of the esophagus. Cancer61, 2022–2026 (1988). ArticleCASPubMed Google Scholar
Wara, W. M., Mauch, P. M., Thomas, A. N. & Phillips, T. L. Palliation for carcinoma of the esophagus. Radiology121 (3 Pt 1), 717–720 (1976). ArticleCASPubMed Google Scholar
Coia, L. R., Soffen, E. M., Schultheiss, T. E., Martin, E. E. & Hanks, G. E. Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. Cancer71, 281–286 (1993). ArticleCASPubMed Google Scholar
Kassam, Z. et al. A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus. Clin. Oncol. (R. Coll. Radiol.)20, 53–60 (2008). ArticleCAS Google Scholar
Kumar, S. et al. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Radiother. Oncol.83, 139–147 (2007). ArticleCASPubMed Google Scholar
Cooper, J. S. et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85–01). Radiation Therapy Oncology Group. JAMA281, 1623–1627 (1999). ArticleCASPubMed Google Scholar
Roussel, A. et al. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial. Int. J. Radiat. Oncol. Biol. Phys.16, 67–72 (1989). ArticleCASPubMed Google Scholar
Homs, M. Y. et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet364, 1497–1504 (2004). ArticlePubMed Google Scholar
Bergquist, H. et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis. Esophagus18, 131–139 (2005). ArticleCASPubMed Google Scholar
Raijman, I., Siddique, I., Ajani, J. & Lynch, P. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest. Endosc.48, 172–179 (1998). ArticleCASPubMed Google Scholar
Morgan, R. A. et al. Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses. Radiology204, 527–532 (1997). ArticleCASPubMed Google Scholar
Dubecz, A. et al. Esophageal stenting for malignant and benign disease: 133 cases on a thoracic surgical service. Ann. Thorac. Surg.92, 2028–2032 (2011). Google Scholar
Sreedharan, A., Harris, K., Crellin, A., Forman, D. & Everett, S. M, Interventions for dysphagia in oesophageal cancer. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD005048 http://dx.doi.org.10.1002/14651858.CD005048.pub2.
Online analysis; Incidence and Mortality. GLOBOCAN 2008[online], (2008).